# Benevolence Industries Incorporated

Health Center, CA
Page: https://astrelis.co/providers/health_center/751011  
This twin: https://astrelis.co/providers/health_center/751011.md  
CMS Certification Number (CCN): 751011  
Release: 2321a4fc37a7 (2026-10-22)

## Headline figures (fiscal years on file: 2022 to 2023)

- **Total patients (UDS) (FY2024):** 13,684. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Operating margin (FY2023):** +12.6%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center
- **Service sites (FY2024):** 10. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Uninsured patient share (FY2024):** 5.0%. Illustrative estimate. Definition: https://astrelis.co/methodology#health-center
- **Total operating revenue (FY2023):** $11.4M. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Total margin (including nonoperating) (FY2023):** +23.2%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center

## Audited financial statements (Federal Audit Clearinghouse)

Read from the FAC-11 template of the audited statements: every line, every ratio and every status column print as the template carries them, and no figure is withheld. A report's tie status says whether its statements foot; a ratio's plausibility status says whether it sits inside its possible range; a median of fewer than five values says so. The figures were not audited by Astrelis. Contract: https://astrelis.co/methodology/fqhc-audit-contract

### Benevolence Industries, Inc., CA

Match to this profile: matched by name (method: name and state).

- FY ending 2024-12-31 (audit year 2024): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2024-12-GSAFAC-0000398856
- FY ending 2023-12-31 (audit year 2023): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2023-12-GSAFAC-0000059826
- FY ending 2022-12-31 (audit year 2022): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2022-12-GSAFAC-0000007571

| Line | FY ending 2024-12-31 | FY ending 2023-12-31 | FY ending 2022-12-31 |
|---|---:|---:|---:|
| cash and investments (current) (Statement of financial position) | 1,814,070 [derived, p.6] | 3,357,082 [derived, p.6] | 144,969 [derived, p.6] |
| patient receivables, net (Statement of financial position) | 2,148,931 [derived, p.6] | 1,621,503 [derived, p.6] | 1,983,919 [derived, p.6] |
| grants and other receivables (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| other current assets (Statement of financial position) | 68,946 [derived, p.6] | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL CURRENT ASSETS (Statement of financial position) | 4,031,947 [extracted, p.6] | 4,978,585 [extracted, p.6] | 2,128,888 [extracted, p.6] |
| property and equipment, net (Statement of financial position) | 6,690,458 [derived, p.6] | -5,329,228 [derived, p.6] | 5,467,750 [derived, p.6] |
| other long-term assets (Statement of financial position) | 208,032 [derived, p.6] | 208,032 [derived, p.6] | 208,032 [derived, p.6] |
| TOTAL ASSETS (Statement of financial position) | 10,930,437 [extracted, p.6] | 10,515,845 [extracted, p.6] | 7,804,670 [extracted, p.6] |
| payables and accrued expenses (Statement of financial position) | 341,697 [derived, p.6] | 247,265 [derived, p.6] | 13,063 [derived, p.6] |
| deferred revenue (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| current debt and leases (Statement of financial position) | 348,825 [derived, p.6] | 470,388 [derived, p.6] | 704,693 [derived, p.6] |
| other current liabilities (Statement of financial position) | 3,626 [derived, p.6] | absent (not printed, or not read) | 3,865 [derived, p.6] |
| TOTAL CURRENT LIABILITIES (Statement of financial position) | 694,148 [extracted, p.6] | 717,653 [extracted, p.6] | 721,621 [extracted, p.6] |
| long-term debt and leases (Statement of financial position) | 3,512,275 [derived, p.6] | 3,830,861 [derived, p.6] | 4,484,124 [derived, p.6] |
| other long-term liabilities (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | 146,035 [derived, p.6] |
| TOTAL LIABILITIES (Statement of financial position) | 4,206,423 [extracted, p.6] | 4,548,514 [extracted, p.6] | 5,351,780 [extracted, p.6] |
| net assets without donor restrictions (Statement of financial position) | 6,724,014 [derived, p.6] | 5,967,331 [derived, p.6] | 2,452,890 [derived, p.6] |
| net assets with donor restrictions (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL NET ASSETS (Statement of financial position) | 6,724,014 [extracted, p.6] | 5,967,331 [extracted, p.6] | 2,452,890 [extracted, p.6] |
| patient service revenue, net (Statement of activities) | 514,703 [derived, p.7] | 1,915,244 [derived, p.7] | 1,201,863 [derived, p.7] |
| pharmacy and 340B revenue (Statement of activities) | 2,743,182 [derived, p.7] | absent (not printed, or not read) | absent (not printed, or not read) |
| federal grants (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| other grants and contracts (Statement of activities) | 2,923,275 [derived, p.7] | 2,300,000 [derived, p.7] | 3,100,273 [derived, p.7] |
| contributions (Statement of activities) | absent (not printed, or not read) | 269,788 [derived, p.7] | absent (not printed, or not read) |
| other revenue (Statement of activities) | 8,837,103 [derived, p.7] | 13,981,953 [derived, p.7] | 10,501,730 [derived, p.7] |
| TOTAL REVENUE AND SUPPORT (Statement of activities) | 15,018,263 [extracted, p.7] | 18,466,985 [extracted, p.7] | 14,803,866 [extracted, p.7] |
| salaries and benefits (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| supplies and pharmaceuticals (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| purchased and professional services (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| occupancy (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| depreciation and amortization (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| interest (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| other expenses (Statement of activities) | 14,261,580 [derived, p.7] | 14,952,544 [derived, p.7] | 12,629,157 [derived, p.7] |
| TOTAL EXPENSES (Statement of activities) | 14,261,580 [extracted, p.7] | 14,952,544 [extracted, p.7] | 12,629,157 [extracted, p.7] |
| OPERATING RESULT (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| non-operating and other changes (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| CHANGE IN NET ASSETS (Statement of activities) | 756,683 [extracted, p.7] | 3,514,441 [extracted, p.7] | 2,174,709 [extracted, p.7] |
| net assets, beginning (Statement of activities) | 5,967,331 [extracted, p.7] | 2,452,890 [extracted, p.7] | 278,181 [extracted, p.7] |
| net assets, end (Statement of activities) | 6,724,014 [extracted, p.7] | 5,967,331 [extracted, p.7] | 2,452,890 [extracted, p.7] |

| Ratio | FY ending 2024-12-31 | FY ending 2023-12-31 | FY ending 2022-12-31 |
|---|---:|---:|---:|
| Days cash on hand | absent [not computed] | absent [not computed] | absent [not computed] |
| Current ratio | 5.81x [plausible] | 6.94x [plausible] | 2.95x [plausible] |
| Operating margin | absent [not computed] | absent [not computed] | absent [not computed] |
| Total margin | 5.0% [plausible] | 19.0% [plausible] | 14.7% [plausible] |
| Patient revenue share | 3.4% [plausible] | 10.4% [plausible] | 8.1% [plausible] |
| Grant dependency | absent [not computed] | absent [not computed] | absent [not computed] |
| Salaries share | absent [not computed] | absent [not computed] | absent [not computed] |
| Days in patient receivables | 1528 days [out of range] | 309 days [plausible] | 603 days [plausible] |
| Debt to net assets | 0.57x [plausible] | 0.72x [plausible] | 2.12x [plausible] |
| Health center award share | absent [not computed] | absent [not computed] | absent [not computed] |

## Sources

HRSA Uniform Data System (awardee level; organization match Verified). CMS HCRIS cost reports, form CMS-224-14, as filed (the Medicare cost-report appendix). Federal Audit Clearinghouse single audits as filed (Benevolence Industries, Inc.; FAC-11 template snapshot, SRC-FAC-001); the organization match is matched by name.

Methodology: https://astrelis.co/methodology · Data sources: https://astrelis.co/data-sources · Data philosophy: https://astrelis.co/data-philosophy

## Cite this page

Astrelis Atlas, "Benevolence Industries Incorporated", https://astrelis.co/providers/health_center/751011, release 2321a4fc37a7 (2026-10-22). Figures as filed in the named public sources; not audited by Astrelis.

Figures are as filed in the named public sources. Astrelis is not a CPA firm and performs no audit, review or attestation of any facility.